{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:04:00Z","timestamp":1789790640657,"version":"4.0.1"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.1248\/bpb.b26-00223","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:12:49Z","timestamp":1789423969000},"page":"1511-1523","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of Doxorubicin Loading into Citrus Lemon-Derived Nanoparticles and Evaluation of Their Antitumor Effects on Tumor Cell Lines"],"prefix":"10.1248","volume":"49","author":[{"given":"Susumu","family":"Suwabe","sequence":"first","affiliation":[{"name":"Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toma","family":"Shinkai","sequence":"additional","affiliation":[{"name":"Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Ozeki","sequence":"additional","affiliation":[{"name":"Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3\u20131 Tanabe-dori, Mizuho-ku, Nagoya 467\u20138603, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. <i>Nat. Cell Biol.<\/i>, <b>10<\/b>, 619\u2013624 (2008).","DOI":"10.1038\/ncb1725"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Payandeh Z, Tangruksa B, Synnergren J, Heydarkhan-Hagvall S, Nordin JZ, Andaloussi SE, Bor\u00e9n J, Wiseman J, Bohlooly-Y M, Lindfors L, Valadi H. Extracellular vesicles transport RNA between cells: Unraveling their dual role in diagnostics and therapeutics. <i>Mol. Aspects Med.<\/i>, <b>99<\/b>, 101302 (2024).","DOI":"10.1016\/j.mam.2024.101302"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lian MQ, Chng WH, Liang J, Yeo HQ, Lee CK, Belaid M, Tollemeto M, Wacker MG, Czarny B, Pastorin G. Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications. <i>J. Extracell. Vesicles<\/i>, <b>11<\/b>, 12283 (2022).","DOI":"10.1002\/jev2.12283"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Cui Y, Gao J, He Y, Jiang L. Plant extracellular vesicles. <i>Protoplasma<\/i>, <b>257<\/b>, 3\u201312 (2020).","DOI":"10.1007\/s00709-019-01435-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Urz\u00ec O, Raimondo S, Alessandro R. Extracellular vesicles from plants: current knowledge and open questions. <i>Int. J. Mol. Sci.<\/i>, <b>22<\/b>, 5366 (2021).","DOI":"10.3390\/ijms22105366"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Perut F, Roncuzzi L, Avnet S, Massa A, Zini N, Sabbadini S, Giampieri F, Mezzetti B, Baldini N. Strawberry-derived exosome-like nanoparticles prevent oxidative stress in human mesenchymal stromal cells. <i>Biomolecules<\/i>, <b>11<\/b>, 87 (2021).","DOI":"10.3390\/biom11010087"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kim DK, Rhee WJ. Antioxidative effects of carrot-derived nanovesicles in cardiomyoblast and neuroblastoma cells. <i>Pharmaceutics<\/i>, <b>13<\/b>, 1203 (2021).","DOI":"10.3390\/pharmaceutics13081203"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Raimondo S, Naselli F, Fontana S, Monteleone F, Lo Dico A, Saieva L, Zito G, Flugy A, Manno M, Di Bella MA, De Leo G, Alessandro R. <i>Citrus limon<\/i>-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death. <i>Oncotarget<\/i>, <b>6<\/b>, 19514\u201319527 (2015).","DOI":"10.18632\/oncotarget.4004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ibrahim S, Tagami T, Kishi T, Ozeki T. Curcumin marinosomes as promising nano-drug delivery system for lung cancer. <i>Int. J. Pharm.<\/i>, <b>540<\/b>, 40\u201349 (2018).","DOI":"10.1016\/j.ijpharm.2018.01.051"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nicklisch SC, Waite JH. Optimized DPPH assay in a detergent-based buffer system for measuring antioxidant activity of proteins. <i>MethodsX<\/i>, <b>1<\/b>, 233\u2013238 (2014).","DOI":"10.1016\/j.mex.2014.10.004"},{"key":"11","unstructured":"11) ELSEVIER. \u201cDoxorubicin, Administration information, pH effect.\u201d: \u2039https:\/\/elsevier.health\/en-US\/preview\/doxorubicin\u203a, accessed 13 November, 2025."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Del R\u00edo JA, Fuster MD, G\u00f3mez P, Porras I, Garc\u00eda-Lid\u00f3n A, Ortu\u00f1o A. <i>Citrus limon<\/i>: a source of flavonoids of pharmaceutical interest. <i>Food Chem.<\/i>, <b>84<\/b>, 457\u2013461 (2004).","DOI":"10.1016\/S0308-8146(03)00272-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) B\u00f6ttger F, Vall\u00e9s-Mart\u00ed A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. <i>J. Exp. Clin. Cancer Res.<\/i>, <b>40<\/b>, 343 (2021).","DOI":"10.1186\/s13046-021-02134-y"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ren JG, Seth P, Ye H, Guo K, Hanai JI, Husain Z, Sukhatme VP. Citrate suppresses tumor growth in multiple models through inhibition of glycolysis, the tricarboxylic acid cycle and the IGF-1R pathway. <i>Sci. Rep.<\/i>, <b>7<\/b>, 4537 (2017).","DOI":"10.1038\/s41598-017-04626-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) de Luna FCF, Ferreira WAS, Casseb SMM, de Oliveira EHC. Anticancer potential of flavonoids: an overview with an emphasis on tangeretin. <i>Pharmaceuticals<\/i>, <b>16<\/b>, 1229 (2023).","DOI":"10.3390\/ph16091229"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Chen C, Sun M, Wang J, Su L, Lin J, Yan X. Active cargo loading into extracellular vesicles: highlights the heterogeneous encapsulation behaviour. <i>J. Extracell. Vesicles<\/i>, <b>10<\/b>, e12163 (2021).","DOI":"10.1002\/jev2.12163"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Xiao Q, Zhao W, Wu C, Wang X, Chen J, Shi X, Sha S, Li J, Liang X, Yang Y, Guo H, Wang Y, Fan JB. Lemon-derived extracellular vesicles nanodrugs enable to efficiently overcome cancer multidrug resistance by endocytosis-triggered energy dissipation and energy production reduction. <i>Adv. Sci.<\/i>, <b>9<\/b>, 2105274 (2022).","DOI":"10.1002\/advs.202105274"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jamshidi Z, Dehghani S, Nameghi MA, Ramezani M, Alibolandi M, Abnous K, Taghdisi SM. Engineering extracellular vesicles derived from lemons for delivering chemotherapeutic drug employing periostin targeting. <i>J. Drug Deliv. Sci. Technol.<\/i>, <b>99<\/b>, 106011 (2024).","DOI":"10.1016\/j.jddst.2024.106011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Baldini N, Torreggiani E, Roncuzzi L, Perut F, Zini N, Avnet S. Exosome-like nanovesicles isolated from <i>Citrus limon<\/i> L. exert antioxidative effect. <i>Curr. Pharm. Biotechnol.<\/i>, <b>19<\/b>, 877\u2013885 (2018).","DOI":"10.2174\/1389201019666181017115755"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kanchanapally R, Deshmukh SK, Chavva SR, Tyagi N, Srivastava SK, Patel GK, Singh AP, Singh S. Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. <i>Int. J. Nanomedicine<\/i>, <b>14<\/b>, 531\u2013541 (2019).","DOI":"10.2147\/IJN.S191313"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Targeted delivery of doxorubicin to HER2 positive tumor models. <i>Int. J. Nanomedicine<\/i>, <b>14<\/b>, 5679\u20135690 (2019).","DOI":"10.2147\/IJN.S210731"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, Yin VP, Lockman P, Bai S. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in <i>Danio rerio<\/i>. <i>Pharm. Res.<\/i>, <b>32<\/b>, 2003\u20132014 (2015).","DOI":"10.1007\/s11095-014-1593-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Brennan K, Martin K, FitzGerald SP, O\u2019Sullivan J, Wu Y, Blanco A, Richardson C, Mc Gee MM. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. <i>Sci. Rep.<\/i>, <b>10<\/b>, 1039 (2020).","DOI":"10.1038\/s41598-020-57497-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Degerstedt O, O\u2019Callaghan P, Clavero AL, Gr\u00e5sj\u00f6 J, Eriksson O, Sj\u00f6gren E, Hansson P, Heindryckx F, Kreuger J, Lennern\u00e4s H. Quantitative imaging of doxorubicin diffusion and cellular uptake in biomimetic gels with human liver tumor cells. <i>Drug Deliv. Transl. Res.<\/i>, <b>14<\/b>, 970\u2013983 (2024).","DOI":"10.1007\/s13346-023-01445-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Rogalska A, Szwed M, Rychlik B. The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells. <i>ScientificWorldJournal<\/i>, <b>2014<\/b>, 819548 (2014).","DOI":"10.1155\/2014\/819548"},{"key":"26","unstructured":"26) ATCC. \u201cMCF-7, Quality control specifications, Population doubling time.\u201d: \u2039https:\/\/www.atcc.org\/products\/htb-22\u203a, accessed 13 November, 2025."},{"key":"27","unstructured":"27) ATCC. \u201cA549, Quality control specifications, Population doubling time.\u201d: \u2039https:\/\/www.atcc.org\/products\/crm-ccl-185\u203a, accessed 13 November, 2025."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Lovitt CJ, Shelper TB, Avery VM. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. <i>BMC Cancer<\/i>, <b>18<\/b>, 41 (2018).","DOI":"10.1186\/s12885-017-3953-6"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/9\/49_b26-00223\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:27:47Z","timestamp":1789788467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/9\/49_b26-00223\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00223","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"b26-00223"}}